Topics:
Arthritis|Imaging In Rheumatology|Lupus|Psoriatic Arthritis|Women's Health And Rheumatology|Geriatrics|Gout|Browse All Topics

Rheumatology Network

Tech Tips Series #1: Managing the Information Barrage

Our goal at RheumNet is always to help you manage the constant flood of online information for rheumatologists. Here, in the first installment of a new series, Advisory Board member Suleman Bhana MD shares tips for saving, sorting, and retrieving journal articles.

Recent Content

Rheumatology Tests and the New Precision Medicine Initiative

Lois Wingerson
News | March 03, 2015 | Rheumatic Diseases, Lupus, Rheumatoid Arthritis
By

Rheumatology tests top the list of FDA-approved biomarker panels today. But the most prominent of these has fallen from favor, and rheumatology doesn't even rate a mention in the Precision Medicine Initiative.

medication risks

How Risky Conversations Fail for Rheumatologists

Rita Baron-Faust
March 02, 2015 | Rheumatoid Arthritis, Musculoskeletal Citations, Rheumatic Diseases
By

When it comes to discussing medication risks, a new study shows, rheumatologists and their patients are speaking different languages. The article reveals how doctors may be sending messages they don't intend.

retinopathy

Hydroxychloroquine Retinopathy: Misunderstood, and Missed

Norman Bauman
March 02, 2015 | Lupus, Musculoskeletal Citations, Rheumatoid Arthritis
By

About half of patients taking hydroxychloroquine, which is used for lupus and rheuamtoid arthritis, aren't tested in time for its blinding effects on the retina, says a review. There are simple ways to use the drug safely.

psoriatic arthritis

Interleukin Inhibitors in Brief

February 25, 2015 | Psoriatic Arthritis, Arthritis, Spondyloarthritis

Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.

More Guidance on Safe Opioid Use

Norman Bauman
February 24, 2015 | Rheumatologic Pain, Musculoskeletal Citations, Osteoarthritis, Rheumatoid Arthritis
By

Articles in two different internal medicine journals last week discussed when and how to use opioids for rheumatologic pain, despite their hazards and limitations.

Baricitinib Excels Placebo for RA in Second Phase 3 Trial

Lois Wingerson
News | February 23, 2015 | Rheumatoid Arthritis, Arthritis
By

The JAK1 and JAK2 inhibitor baricitinib has shown significant results in a second Phase 3 trial for rheumatoid arthritis.

In PsA, Are You Minimizing What You Can't See?

Rita Baron-Faust
February 23, 2015 | Psoriatic Arthritis, Arthritis, Musculoskeletal Citations
By

The first study to ask about variance between physicians and patients in judging the severity of psoriatic arthritis shows that, as with rheumatoid arthritis, they don't reach similar conclusions.

View More Videos
View More Slideshows

By clicking Accept, you agree to become a member of the UBM Medica Community.